A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention.

Drugs that target “epigenetic” changes may help treat or slow the progression of lung cancer.

Each year millions of Americans return to the hospital within 30 days of their previous discharge. Although many readmissions could be preventable, most statistical models for predicting them "perform poorly," according to researchers at Vanderbilt and the Oregon Health and Science University and their affiliated VA medical centers.